CPhI China opens as country invests in R&D

Continued growth in ingredients production with the market set for an increased R&D focus

China, 19 June 2015:CPhI China (#cphichina) –hosted by UBM EMEAand CCCMHPIE and co-organized by UBM Sinoexpo –returns to the Shanghai New International Exhibition Centre, SNIEC, China from 24 to 26 June 2015. The event celebrates a decade in partnership with P-MEC China and will co-locate with ICSE, BioPh, Innopack, LABWorld, Fi Asia China and Hi China.

One of the largest pharmaceutical markets in the world, China is now the leading international producer of pharmaceutical ingredients, and is forecast to reach a staggering $154 billion by 2018. The domestic industry continues to expand at a double-digit rate, driven by improvements in intellectual property protection, increased Government support for R&D, alongside a gentrifying population, expanding medical coverage and growing exports.

Thiseight-shows-in-oneeventbrings China’s entire pharmaceutical supply chain together in one location, with global suppliers of raw materials, ingredients, packaging solutions, machinery, manufacturingand more present– over 30,000visitors are expected to attend. Running parallel to our pharma exhibitions, Fi Asia-China and Hi China will represent the burgeoning food ingredients market and the show also featuresNatural Extracts, Logistics, Finished Formulation, and Environmental Protection & Clean Tech zones.

CPhI & P-MEC China provides the perfect platform to harness the market’s considerable opportunities and has evolved and grown alongside the market for the last 15-years – 2015 sees the floor space expanded to 140,000 square metres, accommodating over 2,800 exhibitors from 100+ countries. An extensive programme of 80+ conferences, summits and seminars will feature across the three-day event, including the 6th China World CEO Summit; 2015 Pharmaceutical R&D innovation and Outsourcing Management Conversation; and 2ndBioPh China Summit 2015, to name just a few.

“CPhI China is an excellent exhibition for manufacturers, buyers and traders, and for sourcing new business;I very much appreciate this type of gathering. Hopefully,CPhI China will continue to return here for a long time.”MunshiDarul Islam, Proprietor & CEO, Total Pharma/Total Herbal & Nutraceuticals.

The CPhI China mobile app, well defined zoning system and the 5th Buyers sourcing event enable attendees to efficiently schedule their time at the show and traverse the diverse range of contacts and businesses. These services aid on-site navigation and help visitors to arrange one-to-one meetings, gather new leads and cement existing business contacts.

Erik Heemskerk, Brand Director at UBM EMEAcommented: “CPhI & P-MEC China continue to expand and meet the demand of the nation’s burgeoning pharmaceutical market. There are huge opportunities in this region for growth, exportation and development, particularly with the Government’s backing to boost the R&D sector. This event plays a critical role in bringing together both domestic and international buyers and suppliers to sustain new business partnerships and continue driving innovation.”

Highlights of CPhI & P-MEC China 2015:

  • Co-location with ICSE, BioPh, Innopack, LABWorld, Fi Asia China and Hi China
  • New Pharma logisticszone
  • Meet with key pharma executives from across the globe and network with potential business partners
  • Extensive programme of conferences, summits and seminars gives great opportunity to learn about the latest innovations, technologies, trends and developments
  • CPhI China mobile app and 5th Buyers sourcing event to enable attendees to efficiently schedule their time

-ENDS-

Notes to editors

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, Southeast Asia, Istanbul, Russia and South America and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit:

The UBM EMEA annual schedule ofPharmaceutical events includes; CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (24-26 June, 2015 at SNIEC- Shanghai, China); CPhI, ICSE Korea (7-9 September, 2015 at the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (13-15 October 2015, IFEMA- Feria de Madrid, Spain); CPhI, P-MEC, ICSE and BioPh India (1-3 December, 2015 at the Bombay Convention and Exhibition Centre, Mumbai, India); CPhI, P-MEC and Innopack South East Asia (06-08 April, 2016 at the Jakarta International Expo- Jakarta, Indonesia);CPhI, ICSE, P-MEC, BioPh and InnoPackJapan (TBCApril, 2016 at the Big Sight Exhibition Centre- Tokyo).

About UBM EMEA

UBM EMEA connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:

Alex Heeley or Tristan Jervis

De Facto Communications

T: +44 207 203 6745 / 6740

E: /